Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

GlobeNewswireSep 5 07:00 ET

Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen's 4th Annual Novel Mechanisms in Neuropsychiatry Summit

GlobeNewswireAug 29 07:00 ET

TD Cowen Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)

TipRanksAug 8 14:26 ET · Ratings

Rapport Therapeutics GAAP EPS of -$1.70 Misses by $1.02

Seeking AlphaAug 8 09:33 ET

Express News | Rapport Therapeutics Ended The Quarter With $336.1M In Cash, Cash Equivalents, And Short-term Investments, Excluding Restricted Cash, Which Is Expected To Fund Operations Through The End Of 2026

BenzingaAug 8 07:58 ET

Express News | Rapport Therapeutics Q2 2024 GAAP EPS $(1.70) Misses $(0.68) Estimate

BenzingaAug 8 07:57 ET